¿¬¼ö°­ÁÂ
2023³â Á¦74Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-04-20

2023³â Á¦74Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-04-20
±³À°ÀÏÀÚ : 2023-04-20
±³À°Àå¼Ò : È£ÅÚ ÀÎÅÍºÒ°í ´ë±¸ ÄÁº¥¼ÇȦAB ¿Ü

±³À°ÁÖÁ¦ : 2023³â Á¦74Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
´ã´çÀÚ : ´ëÇÑÇǺΰúÇÐȸ
¿¬¶ôó : 02-3473-0284  

À̸ÞÀÏ : kda@derma.or.kr

±³À°Á¾·ù : ÇǺΰú

Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡   (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)

Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 23 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 500,000¿ø  

ºñ°í Á¤È¸¿ø 80,000 / ÁØȸ¿ø 40,000 / ºñȸ¿ø 500,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ AB 08:00~08:30 Integrated efficacy and safety of baricitinib in atopic dermatitis and alopecia areata ¿øÁ¾Çö(¿ï»êÀÇ´ë)

±âŸ 04-20 ÄÁº¥¼ÇȦ AB 12:30~12:35 Introduction Chair()

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ AB 12:35~13:20 Melanoma and atypical melanocytic tumors in pediatric population Pedram Gerami(Northwestern University Chicago USA)

Åä·Ð 04-20 ÄÁº¥¼ÇȦ AB 13:20~13:30 Q&A ()

±âŸ 04-20 ÄÁº¥¼ÇȦ AB 13:30~13:35 Introduction Chair()

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ AB 13:35~14:25 ÁøÈ­ÀÇÇÐ - Àΰ£Àº ¿Ö º´¿¡ °É¸®´Â°¡? ÃÖÀçõ(ÀÌÈ­¿©´ë ¼®Á±³¼ö)

Åä·Ð 04-20 ÄÁº¥¼ÇȦ AB 14:25~14:30 Q&A ()

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ AB 15:00~15:50 Hansen disease in 2000: Its diagnosis, treatment and sequele, and understanding of PALs (person affected by leprosy) ä±ÔÅÂ(±¹¸³¼Ò·Ïµµº´¿ø)

Åä·Ð 04-20 ÄÁº¥¼ÇȦ AB 15:50~16:00 Q&A ()

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ AB 16:00~16:15 Alopecia areata ±Ç¿À»ó(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ AB 16:15~16:30 Atopic dermatitis Àå¿ëÇö(°æºÏÀÇ´ë)

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ AB 16:30~16:45 Psoriasis Á¶¼ºÁø(¼­¿ïÀÇ´ë)

Åä·Ð 04-20 ÄÁº¥¼ÇȦ AB 16:45~17:00 Q&A ()

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 09:00~09:50 Antimicrobial treatment for skin infection ±è½Å¿ì(°æºÏÀÇ´ë °¨¿°³»°ú)

Åä·Ð 04-20 ÄÁº¥¼ÇȦ C 09:50~10:00 Q&A ()

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 16:00~16:50 ÀÇ·áºÐÀï»ç·Ê À¯È­Áø(À¯È­Áøº¯È£»ç »ç¹«½Ç)

Åä·Ð 04-20 ÄÁº¥¼ÇȦ C 16:50~17:00 Q&A ()

±âŸ 04-20 ÄÁº¥¼ÇȦ C 10:00~10:05 Overview Chair()

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 10:05~10:20 General information on microbiome and related skin disease ±èÇý¼º(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 10:20~10:35 Currently developed therapy targeting microbiome ¹Ú¿µÁØ(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 10:35~10:50 Cosmetics and microbiome ÀÌÈñÁ¤(Â÷ÀÇ´ë)

Åä·Ð 04-20 ÄÁº¥¼ÇȦ C 10:50~11:00 Q&A ()

±âŸ 04-20 ÄÁº¥¼ÇȦ C 12:30~12:35 Overview Chair()

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 12:35~12:50 Epidemiology and pathogenesis of scabies infestation Á¤ÇýÁ¤(±¹¸³Áß¾ÓÀÇ·á¿ø)

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 12:50~13:05 Clinical manifestation and diagnosis of scabies infestation ÀÌ¿µº¹(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 13:05~13:20 Management of scabies infestation ¼­Çö¹Î(ÇѾçÀÇ´ë)

Åä·Ð 04-20 ÄÁº¥¼ÇȦ C 13:20~13:30 Q&A ()

±âŸ 04-20 ÄÁº¥¼ÇȦ C 13:30~13:35 Overview Chair()

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 13:35~13:50 A deep dive into UVB-based phototherapy ¹æöȯ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 13:50~14:05 Dermatologic area for the phototherapy beyond narrow-band UVB Àå¹Î¼ö(°í½ÅÀÇ´ë)

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 14:05~14:20 LED phototherapy for medical and aesthetic conditions À̽ÃÇü(¼­¿ïÀÇ´ë)

Åä·Ð 04-20 ÄÁº¥¼ÇȦ C 14:20~14:30 Q&A ()

±âŸ 04-20 ÄÁº¥¼ÇȦ C 15:00~15:05 Overview Chair()

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 15:05~15:20 Resident memory CD4 T cell in skin - Allergic contact dermatitis ½Å±âÇõ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 15:20~15:35 Resident memory CD8 T cell in skin - Alopecia areata ¹ÚÇö¼±(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-20 ÄÁº¥¼ÇȦ C 15:35~15:50 Resident memory B cell in skin - Pemphigus ±èÁ¾ÈÆ(¿¬¼¼ÀÇ´ë)

Åä·Ð 04-20 ÄÁº¥¼ÇȦ C 15:50~16:00 Q&A ()

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 09:00~09:15 Surgical anatomy of head and neck ¿Àº´È£(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 09:15~09:30 Local and regional anesthesia ¹éÀ¯»ó(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 09:30~09:45 Various biopsy methods and suture technics ¹ÚÁöÇý(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 09:45~10:00 How to design and perform basic local skin flaps ÃÖÁö¿õ(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 10:00~11:00 Lets' try to do a conventional two layer wound closure/rotation flap by my self ³ë¹Ì·É(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 12:30~12:47 Introduction and general concept in the diagnosis of Behçet''s disease: Diagnostic criteria and markers ÀÌÀº¼Ò(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 12:47~13:04 Pitfalls in the diagnosis of Behçet''s disease: Mucocutaneous manifestations ±èµµ¿µ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 13:04~13:21 Update in the management of Behçet''s disease ³ëÁÖ¿µ(ÀÌÈ­ÀÇ´ë)

Åä·Ð 04-20 Áñ°Å¿îȦ 13:21~13:30 Q&A ()

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 13:30~13:47 Specialized skin type the aspect of cosmetics ±èÀºÁÖ(¾Æ¸ð·¹ÆÛ½ÃÇÈ)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 13:47~14:04 Skin type in Korean ±èÁ¤Àº(ÇѾçÀÇ´ë)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 14:04~14:21 Application of skin type in clinics È«¿ø±Ô(ÈÞ¸ÕÇǺΰú)

Åä·Ð 04-20 Áñ°Å¿îȦ 14:21~14:30 Q&A ()

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 15:00~15:17 Single-cell omics in skin cancer ½ÉÁØÈ£(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 15:17~15:34 Single-cell omics in atopic dermatitis Áø¼±ÇÊ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 15:34~15:51 Single-cell omics in psoriasis ±èűÕ(¿¬¼¼ÀÇ´ë)

Åä·Ð 04-20 Áñ°Å¿îȦ 15:51~16:00 Q&A ()

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 16:00~16:17 Biologics in lupus ÀÌ»óÁø(°æºÏÀÇ´ë ·ù¸¶Æ¼½º³»°ú)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 16:17~16:34 Management of alopecia in lupus ±èµµ¿µ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-20 Áñ°Å¿îȦ 16:34~16:51 Scar management in lupus ¹Ú±Í¿µ(Áß¾ÓÀÇ´ë)

Åä·Ð 04-20 Áñ°Å¿îȦ 16:51~17:00 Q&A ()

±âŸ 04-20 ÇູÇÑȦ 08:00~08:10 Àλ縻 ±èÀ¯Âù(´ëÇÑÇǺΰúÇÐȸ ȸÀå)

±âŸ 04-20 ÇູÇÑȦ 08:10~08:40 ´ëÇÑÇǺΰúÇÐȸ ¼Ò°³ ÀÌÁö¹ü(´ëÇÑÇǺΰúÇÐȸ Ãѹ«ÀÌ»ç)

±³À°½Ã°£ 04-20 ÇູÇÑȦ 08:40~09:30 ÇǺΰú Àü°øÀÇ ¿¬Â÷º° ¼ö·Ã ¸ñÇ¥ ¹× ³»¿ë À¯¹Ú¸°(´ëÇÑÇǺΰúÇÐȸ ±³À°ÀÌ»ç)

±³À°½Ã°£ 04-20 ÇູÇÑȦ 09:30~10:20 ÇǺΰú Àü°øÀÇ ¼ö·Ã °úÁ¤ÀÇ Æò°¡ À¯¹Ú¸°(´ëÇÑÇǺΰúÇÐȸ ±³À°ÀÌ»ç)

±³À°½Ã°£ 04-20 ÇູÇÑȦ 10:20~11:10 ÇǺΰú Àü¹®ÀÇ ÀڰݽÃÇè (2024) °³¿ä ¾ÈÈ¿Çö(´ëÇÑÇǺΰúÇÐȸ °í½ÃÀÌ»ç)

±³À°½Ã°£ 04-20 ÇູÇÑȦ 11:10~12:00 ³í¹®ÀÛ¼º¹ý ÀÌ°æÈ£(´ëÇÑÇǺΰúÇÐȸ °£ÇàÀÌ»ç)

Åä·Ð 04-20 ÇູÇÑȦ 12:00~12:10 Q&A ()

±³À°½Ã°£ 04-20 ÇູÇÑȦ 12:30~13:20 DMF case reports in Europe and Korean case presentation ³²Çö¹Î(´ëÀÚÀκ´¿ø)

Åä·Ð 04-20 ÇູÇÑȦ 13:20~13:30 Q&A ()

±³À°½Ã°£ 04-20 ÇູÇÑȦ 13:30~14:20 The latest trend of onychomycosis treatment ÇÏ´ë·æ(°æºÏÀÇ´ë)

Åä·Ð 04-20 ÇູÇÑȦ 14:20~14:30 Q&A ()

±³À°½Ã°£ 04-20 ÇູÇÑȦ 15:00~15:50 Dutasteride: long-term favorite 5¥á-RI for Koreans in the real world ±è¹Î¼º(Á¶¼±ÀÇ´ë)

Åä·Ð 04-20 ÇູÇÑȦ 15:50~16:00 Q&A ()

±³À°½Ã°£ 04-20 ÇູÇÑȦ 16:00~16:25 Doxycycline in the treatment of acne ½Å¹Î°æ(°æÈñÀÇ´ë)

±³À°½Ã°£ 04-20 ÇູÇÑȦ 16:25~16:50 Anti-inflammatory dose of doxycycline in the treatment of rosacea and other skin disease ÀÌ¿µº¹(°¡Å縯ÀÇ´ë)

Åä·Ð 04-20 ÇູÇÑȦ 16:50~17:00 Q&A ()

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù) : 2024-05-18

±³À°ÀÏÀÚ : 2024-05-18 ±³À°Àå¼Ò : ¿Â¶óÀÎ (24½Ã°£ VOD ´çÀÏ ¼ÛÃâ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù)ÁÖÃÖ±â°ü : ¼­¿ïƯ

Ãßõ¼ö : 1 , Á¶È¸¼ö : 564 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ 16th Vascular Ultrasound Seoul Update 2023 Symposium (2ÀÏÂ÷) : 2024-04-21

±³À°ÀÏÀÚ : 2024-04-21 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø ÁöÇÏ 1Ãþ ´ë°­´ç ±³À°ÁÖÁ¦ : 16th Vascular Ultrasound Seoul Update 2023

Ãßõ¼ö : 0 , Á¶È¸¼ö : 592 , ´ñ±Û¼ö : 0

[ºÎ»ê] ´ëÇÑ°ñÀýÇÐȸ Á¦50Â÷ Çмú´ëȸ(1ÀÏÂ÷) : 2024-04-26

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ºÎ»ê ±³À°ÁÖÁ¦ : ´ëÇÑ°ñÀýÇÐȸ Á¦50Â÷ Çмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ°ñÀýÇÐȸ ´ã´çÀÚ : Á¤À¯Áø ¿¬¶ôó : 031-551

Ãßõ¼ö : 0 , Á¶È¸¼ö : 443 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-04-17

±³À°ÀÏÀÚ : 2024-04-17 ±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ºÎ»ê ±³À°ÁÖÁ¦ : 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ ´ã´çÀÚ : °­ÈÆ ¿¬¶ôó

Ãßõ¼ö : 0 , Á¶È¸¼ö : 561 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) 2023³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù) : 2023-05-20

±³À°ÀÏÀÚ : 2023-05-20 ±³À°Àå¼Ò : ¿Â¶óÀÎ (VOD ´çÀÏ 24½Ã°£ ¼ÛÃâ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2023³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù)ÁÖÃÖ±â°ü : ¼­¿ïƯ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,108 , ´ñ±Û¼ö : 0